SIGA TECHNOLOGIES INC
SIGA$475M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEW YORK39 employees
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.
Drugs in Pipeline
4
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
SIGA News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
tecovirimat
Smallpox
TPOXX
Smallpox
Smallpox and Mpox Vaccine
Smallpox
ST-246 400 mg
Orthopoxviral Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
tecovirimat | Phase 3 | Smallpox | - | - |
TPOXX | Phase 3 | Smallpox | - | - |
Smallpox and Mpox Vaccine | Phase 2 | Smallpox | - | - |
ST-246 400 mg | Phase 2 | Orthopoxviral Disease | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply